Skip to main content
    P

    Phibro Animal Health Corporation (PAHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $34.92
    -0.10 (-0.29%)

    Market Cap: $1.42B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Phibro Animal Health Corporation (PAHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Phibro Animal Health (PAHC) has a market cap of $1.42B and an enterprise value of $2.08B. Its trailing P/E of 10.7x is below its 10-year median of 16.9x. Its return on invested capital of 11.69% compares with a 7.08% median across 10 similar companies.

    Total Valuation

    Enterprise value is 46.37% above the market cap, as debt exceeds cash.

    Market Cap$1.42B
    Enterprise Value$2.08B
    Latest price (Nov 17, 2026)$34.92

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 25, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Next Ex-Dividend DateNov 25, 2026
    Next Payment DateDec 16, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count grew 0.07% a year over 3 years.

    Shares Outstanding40.59M
    Shares Change (YoY)+0.14%
    Share Count Growth (3Y CAGR)+0.07%

    Valuation Ratios

    Sales and book value multiples are 0.9x and 3.4x. Its year-end P/E ranged from 10.2x to 21.8x from 2016 to 2025.

    P/E Ratio10.7x
    Forward P/E9.8x
    P/S Ratio0.9x
    Forward P/S0.9x
    P/B Ratio3.4x
    P/TBV Ratio4.3x
    P/FCF Ratio65.4x
    P/OCF Ratio16.6x
    PEG Ratio0.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.7x EBITDA and 95.8x free cash flow.

    EV / Earnings20.3x
    EV / Sales1.4x
    EV / EBITDA8.7x
    EV / EBIT11.3x
    EV / FCF95.8x

    Price Statistics

    The stock is down 21.88% over 52 weeks and trades 4.69% below its 50-day average.

    Beta (1Y)0.94
    52-Week Change-21.88%
    1-Month Change-11.24%
    3-Month Change-1.17%
    6-Month Change+3.71%
    5-Year Change+77.21%
    10-Year Change+49.83%
    Total Return (1Y)-20.81%
    Total Return (3Y CAGR)+50.04%
    Total Return (5Y CAGR)+12.62%
    Return vs SPY (1Y)-30.35%
    Max Drawdown (1Y)-52.28%
    Max Drawdown (3Y)-52.28%
    Sharpe Ratio (1Y)-0.37
    Correlation with SPY (1Y)0.23
    50-Day Average$36.64
    200-Day Average$40.85
    52-Week Range$28.04 to $59.64
    RSI (14 Days)42.6
    Average Volume (20 Days)204.06K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.20x current liabilities, and total debt is 1.76x shareholder equity.

    Current Ratio3.20x
    Quick Ratio1.28x
    Debt / Equity1.76x
    Debt / EBITDA3.09x
    Debt / FCF33.91x

    Returns and Efficiency

    Return on invested capital is 11.69% over the last 12 months, against a 5-year average of 7.16%.

    Return on Equity (ROE)24.59%
    Return on Assets (ROA)6.78%
    Return on Invested Capital (ROIC)11.69%
    Return on Capital Employed (ROCE)15.06%
    ROE (5Y Average)14.80%
    ROA (5Y Average)3.81%
    ROIC (5Y Average)7.16%
    Asset Turnover1.06x
    Inventory Turnover1.85x
    Receivables Turnover6.69x
    Cash Conversion Cycle205 days

    Taxes

    Income tax took 26.56% of pretax income over the last 12 months.

    Income Tax (TTM)$37.14M
    Effective Tax Rate26.56%

    Scores

    PAHC has an Altman Z-Score of 3.06, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score3.06
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.54B over the last 12 months is up 10.10% from the 12 months before.

    Revenue$1.54B
    Revenue Growth (YoY)+10.10%
    Gross Profit$521.27M
    Operating Income$192.78M
    Pretax Income$139.86M
    Net Income$102.71M
    EBITDA$238.14M
    EBIT$183.52M
    Reported EPS (TTM)$3.27

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.66% of the $1.51B in total assets.

    Cash and Equivalents$75.55M
    Total Debt$734.88M
    Net Debt$659.33M
    Net Debt Per Share$16.24
    Working Capital$649.38M
    Shareholder Equity$417.67M
    Book Value Per Share$10.29
    Tangible Book Value$329.33M
    Tangible Book Per Share$8.11
    Total Assets$1.51B
    Total Liabilities$1.10B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $64.06M of capital spending, operating cash flow left $21.67M of free cash flow.

    Operating Cash Flow$85.73M
    Capital Expenditures$64.06M
    Free Cash Flow$21.67M
    FCF Per Share$1.03
    Depreciation and Amortization$54.62M
    Dividends Paid$19.47M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 12.51%, against a 5-year average of 8.46%.

    Gross Margin33.83%
    Operating Margin12.51%
    Pretax Margin9.08%
    Net Margin6.67%
    EBITDA Margin15.45%
    EBIT Margin11.91%
    FCF Margin1.41%
    Gross Margin (5Y Average)31.23%
    Operating Margin (5Y Average)8.46%
    Net Margin (5Y Average)3.82%

    Growth

    Revenue grew 15.79% a year over 3 years, and EPS 38.05% a year.

    Revenue Growth (3Y CAGR)+15.79%
    Revenue Growth (5Y CAGR)+12.74%
    EPS Growth (3Y CAGR)+38.05%
    EPS Growth (5Y CAGR)+20.38%
    FCF Growth (5Y CAGR)-12.27%
    Operating Income Growth (3Y CAGR)+39.35%

    Revenue and profit by year

    Dividends and Yields

    PAHC pays out 18.97% of earnings as dividends.

    Dividend Per Share (Annual)$0.48
    Dividend Yield1.37%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)0.00%
    Payout Ratio18.97%
    FCF Payout Ratio89.85%
    Earnings Yield9.35%
    FCF Yield1.53%
    Shareholder Yield1.37%

    Full dividend history

    Peer Position

    Against 11 similar companies, PAHC has the 6th highest P/E.

    P/E Ratio10.7x vs 10.3x median
    P/S Ratio0.9x vs 2.0x median
    ROIC11.69% vs 7.08% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.10% vs +14.45% median
    Dividend Yield1.37% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.73% and EPS growth at 9.96% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.73%
    EPS Growth Forecast (2Y CAGR)+9.96%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PAHC

    What is PAHC's market cap?

    Phibro Animal Health has a market cap of $1.42B. Its enterprise value, which adds debt and subtracts cash, is $2.08B.

    What is PAHC's P/E ratio?

    Phibro Animal Health has a trailing P/E ratio of 10.7x and a forward P/E of 9.8x.

    How many shares of PAHC are outstanding?

    Phibro Animal Health has 40.59M shares outstanding. The count is up 0.14% from a year earlier.

    Does PAHC pay a dividend?

    Yes. Phibro Animal Health pays $0.48 a share a year, a dividend yield of 1.37%.

    How much debt does PAHC have?

    Phibro Animal Health has $734.88M of total debt and $75.55M of cash and equivalents, a net debt position of $659.33M.